Replies to post #2315012 on MOMO'S BREAKOUT BOARD

[$ubmachine]

Alpha Synuclein is key protein which plays main role in yesterday`s Parkinson Breakthrough News from MJFF

ACIU again had from all related companies the most number of Alpha Synuclein drugs under development in 2022 !!!

From their current pipeline:
In their Parkinson related Clinical stage program ACI-7104 and ACI-12589 are on alpha-synuclein for Parkinsons desease.
In their Parkinson related Novel targets program Anti-a-syn antibody and Morphomer® a-syn aggregation inhibitor are on alpha-synuclein for Parkinsons desease.

See complete ACIU pipeline